is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Senescence Life Sciences, or “Senescence,” is a bio-technology leader operating in the pharmaceutical and consumer health sectors. Senescence’s mission is to research, develop and commercialize safe, effective and scientifically proven neuroprotective compounds that address age-related cognitive decline. Leveraging the latest and most significant advances in neuroscience, Senescence has developed a multi-therapeutic approach designed to target the key mechanisms behind the cellular and molecular manifestations of neuronal aging. Senescence’s research, in combination with leading laboratories around the world, supports the premise that interventions at these key targets carry substantive benefits for the aging brain.
Dr. Shawn Watson serves as CEO of Senescence and is responsible for overseeing both the pharmaceutical and health & wellness business lines. Dr. Watson also plays an active role in many ongoing research projects regarding brain health and is the principal investigator for Senescence.